Journal: Biomedicines
Article Title: Ιnterleukin-17A-Enriched Neutrophil Extracellular Traps Promote Immunofibrotic Aspects of Childhood Asthma Exacerbation
doi: 10.3390/biomedicines11082104
Figure Lengend Snippet: Human embryonic lung fibroblasts (HELFs) acquire a pro-fibrotic phenotype upon treatment with in vitro-generated asthma exacerbation NETs. HELFs were incubated with NETs released from control neutrophils upon stimulation with asthma serum (asthma NETs). ( A ) Migration/wound healing potential (original magnification, 40×) in HELFs stimulated with asthma NETs, assessed via light microscopy. ( B ) Fluorescence microscopy images showing CCN2 staining (blue, DAPI; green, CCN2; original magnification, 100×) and migration/wound healing capacity in HELFs treated with asthma NETs and ( C ) production of collagen ( n = 6 independent experiments). To hinder IL-17A signaling, asthma NETs were pre-incubated with a neutralizing antibody against IL-17A. DNase I was used to dismantle NETs. For ( A , B ), representative examples of 4 independent experiments are shown. For ( C ), data are shown as mean ± SD, Kruskal–Wallis test. All conditions were compared to untreated (statistically significant: p < 0.05).
Article Snippet: Human embryonic lung fibroblasts (HFL-1, Cat#: CCL-153, American Type Culture Collection, Manassas, WV, USA) were cultured at 37 °C with 5% CO 2 in culture medium, consisting of low-glucose Dulbecco’s Modified Eagle’s Medium (DMEM, Thermo Fisher Scientific, Waltham, MA, USA), 10% v / v fetal bovine serum (FBS, Thermo Fisher Scientific, Waltham, MA, USA), 100 U/mL Antibiotic-Antimycotic (Biosera, Cholet, France) and 5% v / v MEM non-essential amino acids solution (Thermo Fisher Scientific, Waltham, MA, USA).
Techniques: In Vitro, Generated, Incubation, Control, Migration, Light Microscopy, Fluorescence, Microscopy, Staining